XML 46 R35.htm IDEA: XBRL DOCUMENT v3.25.0.1
Stock-based Awards (Tables)
 12 Months Ended
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Summary of stock option activity
A summary of the Company’s stock option activity for the year ended December 31, 2024 is as follows:
 Number of OptionsWeighted-Average Exercise PriceWeighted-Average Remaining Contractual Life
Aggregate Intrinsic Value (1)
 (in years)(in millions)
Outstanding at December 31, 20232,240,898 $10.65 3.1 
Granted— —   
Exercised(22,727)2.68   
Forfeited/expired(900,048)12.37   
Outstanding at December 31, 20241,318,123 $9.61 3.5$0.2 
Vested and expected to vest at December 31, 20241,318,123 $9.61 3.5$0.2 
Exercisable at December 31, 2024
1,296,249 $9.69 3.4$0.2 
(1)The aggregate intrinsic value represents the excess of the closing price of the Company’s common stock of $3.73 on December 31, 2024 over the exercise price of in-the-money stock option awards.
Schedule of activity in connection with the restricted stock units
A summary of the Company’s restricted stock unit (“RSU”) activity for the year ended December 31, 2024 is as follows:
 Number of SharesWeighted-Average Grant Date Fair Value
Non-vested — December 31, 2023
5,763,510 $2.94 
Granted3,784,400 3.49 
Vested(2,766,719)3.16 
Forfeited(1,298,214)3.22 
Non-vested — December 31, 2024
5,482,977 $3.15 
A summary of the Company’s PSU activity for the year ended December 31, 2024 is as follows:
 
Performance Share Units
Weighted-Average Grant Date Fair Value
Outstanding — December 31, 2023
2,518,556 $4.18 
Granted1,231,577 4.39 
Vested(364,837)5.99 
Forfeited(131,555)5.25 
Outstanding — December 31, 2024
3,253,741 $4.01 
Schedule of fair value of stock option awards The following weighted-average assumptions were used in estimating the fair value of the PSUs at the date of grant:
 
Year Ended December 31,
 202420232022
Expected volatility of common stock
62 %67 %64 %
Expected volatility of Index
24 %31 %30 %
Average correlation coefficient of the Company and the Index
0.420.370.32
Risk-free interest rate
4.27 %4.59 %2.55 %
Expected term (years)
3.032.962.95
Schedule of stock-based compensation cost relating to stock options, restricted stock awards and RSUs
The Company recorded stock-based compensation cost relating to stock options, RSUs, and PSUs in the following categories on the accompanying consolidated statements of comprehensive loss (in thousands):
 Year Ended December 31,
 202420232022
Cost of revenue$260 $191 $185 
Sales and marketing1,804 3,592 4,884 
Technology and development2,022 3,500 4,186 
General and administrative7,644 7,016 8,426 
Total stock-based compensation expense11,730 14,299 17,681 
Amount capitalized to internal-use software728 838 1,019 
Total stock-based compensation cost$12,458 $15,137 $18,700